Global Medical REIT - GMRE Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GMRE shares.
View GMRE analyst ratings or view top-rated stocks.

2 brokers have issued 12-month price targets for Global Medical REIT's shares. Their GMRE share price forecasts range from $16.00 to $17.00. On average, they anticipate the company's share price to reach $16.50 in the next twelve months. This suggests a possible upside of 40.4% from the stock's current price.
View analysts price targets for GMRE or view top-rated stocks among Wall Street analysts.

Global Medical REIT's stock was trading at $17.75 at the start of the year. Since then, GMRE stock has decreased by 33.8% and is now trading at $11.75.
View the best growth stocks for 2022 here.

Global Medical REIT is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our GMRE earnings forecast.

Global Medical REIT Inc. (NYSE:GMRE) posted its quarterly earnings results on Wednesday, May, 4th. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.23 by $0.19. Global Medical REIT had a net margin of 13.31% and a trailing twelve-month return on equity of 2.96%. During the same quarter last year, the company earned $0.24 EPS.

Global Medical REIT declared a quarterly dividend on Friday, June 10th. Stockholders of record on Friday, June 24th will be given a dividend of $0.21 per share on Friday, July 8th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 7.15%. The ex-dividend date of this dividend is Thursday, June 23rd.
Read our dividend analysis for GMRE.

Global Medical REIT (NYSE:GMRE) pays an annual dividend of $0.84 per share and currently has a dividend yield of 7.13%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 442.13%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, GMRE will have a dividend payout ratio of 81.55% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for GMRE.

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Principal Financial Group (PFG), INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Block (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

(GMRE) raised $130 million in an initial public offering (IPO) on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Global Medical REIT's stock is owned by a variety of institutional and retail investors. Top institutional investors include Brown Advisory Inc. (1.91%), Aew Capital Management L P (1.52%), State of New Jersey Common Pension Fund D (1.50%), Allspring Global Investments Holdings LLC (0.62%), Sound Income Strategies LLC (0.60%) and Monarch Partners Asset Management LLC (0.33%). Insiders that own company stock include Henry Cole, Jeffrey Busch and Ronald Marston.
View institutional ownership trends.

Shares of GMRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of GMRE stock can currently be purchased for approximately $11.75.

Global Medical REIT (NYSE:GMRE) has a market capitalization of $769.84 million and generates $115.94 million in revenue each year. The company earns $17.62 million in net income (profit) each year or $0.19 on an earnings per share basis.

Global Medical REIT employs 26 workers across the globe.

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The official website for the company is www.globalmedicalreit.com. The company can be reached via phone at (202) 524-6851 or via email at investors@globalmedicalreit.com.